S2328 The Effect of GLP-1 RA Use on Gastric Emptying and Gastroparesis Symptoms in Patients With Diabetic Gastroparesis: A Systematic Review

Jacob Itkin,Sudheer M. Dhoop,Thomas Sodeman
DOI: https://doi.org/10.14309/01.ajg.0001038680.08387.b9
2024-10-26
The American Journal of Gastroenterology
Abstract:Gastroparesis (GP) is a condition characterized by delayed gastric emptying without mechanical obstruction commonly observed in patients with diabetes mellitus, often due to autonomic neuropathy. The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in diabetes management is on the risk and has raised concerns about their potential to exacerbate gastroparesis. This review aims to summarize the findings from various studies investigating the relationship between GLP-1 RAs and gastric emptying in diabetic gastroparesis.
gastroenterology & hepatology
What problem does this paper attempt to address?